Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SILO

SILO Pharma Inc

Jun 09 • 04:00PM ET

6.46

+0.20 3.19 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-7.46	Insider Own	1.69%	Shs Outstand	1.08M	Perf Week	23.01%
Market Cap	7.01M	Forward P/E	-	EPS next Y	-	Insider Trans	37.51%	Shs Float	1.07M	Perf Month	6.34%
Enterprise Value	0.74M	PEG	-	EPS next Q	-	Inst Own	6.49%	Short Float	2.01%	Perf Quarter	24.18%
Income	-4.84M	P/S	100.14	EPS this Y	-	Inst Trans	-	Short Ratio	0.08	Perf Half Y	-1.85%
Sales	0.07M	P/B	1.23	EPS next Y	-	ROA	-74.99%	Short Interest	0.02M	Perf YTD	26.67%
Book/sh	5.24	P/C	1.12	EPS next 5Y	-	ROE	-99.94%	52W High	15.15 -57.36%	Perf Year	-30.69%
Cash/sh	5.78	P/FCF	-	EPS past 3/5Y	33.45% 26.52%	ROIC	-85.24%	52W Low	3.32 94.87%	Perf 3Y	-81.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.00% -	Gross Margin	-1244.34%	Volatility	14.53% 11.61%	Perf 5Y	-96.92%
Dividend TTM	-	EV/Sales	10.57	EPS Y/Y TTM	56.28%	Oper. Margin	-6631.16%	ATR (14)	0.70	Perf 10Y	-99.14%
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	0.00%	Profit Margin	-6717.40%	RSI (14)	54.31	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	47.76%	SMA20	9.02%	Beta	0.74	Target Price	150.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	0.00%	SMA50	0.87%	Rel Volume	0.06	Prev Close	6.26
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-6.02%	Avg Volume	273.12K	Price	6.46
IPO	May 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	16,762	Change	3.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)